Skip to main content

Topic

stem cell research

198 published works

  1. Microjuris Blog

    Proponen legislación para obligar a planes médicos a cubrir terapias con células madre

    By Coleccionesmjpr

    El proyecto establece la obligación de que todo plan médico incluya como cubierta esencial aquellos tratamientos clínicos con células madre aprobados por la FDA

  2. The IPKat

    Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell)

    By Dr Rose Hughes

    Patenting stem cell therapies in the US is a difficult business, especially if your cell therapy product is defined solely by natural surface cell markers and lacks any form of…

  3. The Faculty Lounge

    Stem Cell Donation at . . . ESPN?

    Yep. And it's a fascinating story. I’m told by the cricket lover in my house that Bavuma is a hero for other reasons, but it is his activism on stem…

  4. The Patent Playbook

    Federal Circuit Affirms Stem Cell Product-by-Process Claims: Lessons in Claim Construction and Inherency from <em>Restem LLV v. Jadi Cell LLC</em>

    By Joseph Drayton, Erik Milch, Connor Villar

    The Federal Circuit issued a precedential opinion on March 4, 2025, that serves as valuable guidance for product-by-process claims, particularly in the context of inherency in claim construction. In Restem,…

  5. Regulatory Oversight

    Arizona AG Takes Action Against Company for Alleged Deceptive Marketing Practices

    By Troutman Pepper Locke State Attorneys General Team, Dascher Pasco

    Earlier this month, Arizona Attorney General (AG) Kris Mayes announced a lawsuit alleging that CBR Systems, Inc. (CBR), one of the nation's largest cord blood banking companies, engaged in deceptive…

  6. Drug & Device Law

    Fat Cell Slurry is a Drug

    By Stephen McConnell

    United States v. Cal. STEM Cell Treatment Cntr., Inc., 2024 U.S. App. LEXIS 24525 (9th Cir. 2024), is not, strictly speaking, a product liability case at all.  But it hits…

  7. DC Medical Malpractice & Patient Safety Blog

    FDA dithers dangerously on regulating sketchy ‘stem cell’ care and kid vaping

    By Patrick A. Malone

    Yet more derelictions of duty by the federal Food and Drug Administration are happening now, in its handling of largely hokum treatments and health-threatening devices.  The latest examples: drug safety regulators…

  8. Mahany Law Blog

    Hundreds of Unlicensed Stem Cell Clinics

    By Brian Mahany

    There Are Thousands of Unapproved Stem Cell Clinics in the U.S. At Best, You Are Throwing Away Your Money, at Worst, Your Life An investigation by the Arizona Republic found…

  9. Mahany Law Blog

    Invitrx Stem Cell Patients Beware – FDA Issues Stern Warning Letter

    By Brian Mahany

    Stem Cell Maker Invitrx Is in Trouble Again. Are Its Products Safe? You Be the Judge! We are one of the few law firms still handling stem cell lawsuits. The…

  10. Domnick Cunningham & Whalen Blog

    Unregulated Stem Cell Therapy Brings More Harm Than Help

    By Ian Jack

    In September 2019, the U.S. Food and Drug Administration (FDA) issued a warning to consumers: “Watch out for unapproved stem cell therapies!” The warning comes from the agency in response…